Teva Pharmaceutical Industries News
News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.
23 hrs ago | Sys-Con Media
The SYNERGY Phase 3 trial is designed to evaluate a survival benefit for custirsen, in combination with first-line docetaxel chemotherapy, in men with metastatic castrate-resistant prostate cancer, or CRPC.
Trending on the Topix Network
Yesterday | Reuters
Teva Pharmaceutical Industries Ltd agreed to pay $27.6 million to settle charges that it paid kickbacks to a Chicago psychiatrist to induce him to prescribe an anti-schizophrenia drug to patients, resulting in more than 100,000 false Medicaid and Medicare claims.
Yesterday | The Washington Post
Teva Pharmaceutical Industries Ltd.'s early progress in shifting daily Copaxone takers to a new formulation has persuaded some analysts the drugmaker may succeed in converting as many as half of its multiple sclerosis patients.
The company has already hired 60 new employees who w... )--California Association of Community Managers , the state's leading community association management education organization, has launched a statewide pro... )--This year, MedImpact Healthcare Systems, Inc. celebrates 25 years of providing pharmacy benefit management services to health plans, ... (more)
NORTH WALES, Pa. & BURLINGTON, Vt.-- --Teva Pharmaceuticals USA, a subsidiary of Teva Pharmaceutical Industries Ltd. and Volunteers in Medicine , a national nonprofit organization dedicated to helping communities provide free primary healthcare clinics for families and individuals, today announced their 2014 National Partnership to make healthcare ... (more)
Aunque la mayoria de la gente la conoce como la esposa d... )--The Biotechnology Industry Organization applauds Reps.
Alexza Pharmaceuticals, Inc. today reported financial results for the quarter and year ended December 31, 2013.
Antares Pharma, Inc. today announced it will release its fourth quarter 2013 financial results before the market opens on Thursday, March 13, 2014, and host a conference call shortly thereafter at 8:30 a.m. ET to discuss the results.
Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies maintain the highest amount of guru ownership.
Mar. 4, 2014-- Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to Evista Tablets, 60 mg, in the United States.
Owl Creek Asset Management was founded in 2001 in New York by Jeffrey Altman , its current manager.
This time last year, the chairman and chief executive officer of Israel's Teva Pharmaceutical Industries Ltd. , the world's biggest generic drugmaker, were foreigners.
Key positions she has held include Group Executive Vice President and Global Head of Quality for Teva Pharmaceutical Industries Ltd., Senior Vice President of Quality at Wyeth Pharmaceuticals, Senior Vice President of Quality at Barr Pharmaceuticals, Head of U.S. Quality of has been active in the pharmaceutical industrial and regulatory environment ... (more)